Summary of mean FB ratio distribution across racial groups. by Zoë Dinkel (21402766)

Summary of group means, standard deviations, t-statistics, and P-values. by Zoë Dinkel (21402766)

Cinacalcet administered early in the inactive phase markedly decrease parathyroid Ki-67 index. by Søren Egstrand (10906087)

“…All groups were compared by Kruskal Wallis test with <i>post hoc</i> test after Dunn with Bonferroni adjustment showing significant decreased Ki-67 labeling index of <i>Cina1</i> compared to <i>Cina2</i> (p = 0.006) and the untreated CKD groups (p = 0.0001 and p = 0.0002, respectively). …”

Forest plots illustrate the mean difference in; (A) hospital stay, (B) ICU stay, (C) intubation time; with subgroup analysis. by Mohamed R. Abdelraouf (21501468)

Mean (95% CI) and standard deviation of Co-Contraction index of right and left gluteus medius (MVC%) during 60 minutes standing between two groups. by Saeedeh Abbasi (9423189)

The mean number of the emerged <i>D. melanogaster</i> adults. Mean number (±SE) of emerged adults and average percentage (±SE) of the residual fertility at the different treatment... by Flavia Cerasti (21655934)

Maximum likelihood estimates of trans-log mean stochastic function. by James Anaba Akolgo (14129379)

Summary of post-treatment disease course measures from MDMA-AT publications. by Filip Stanicic (17808254)

Subjects:

Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications. by Filip Stanicic (17808254)

Subjects:

Disease course measures after the PTSD treatments. by Filip Stanicic (17808254)

Subjects:

Summary of post-treatment CAPS score changes from MDMA-AT publications. by Filip Stanicic (17808254)

Subjects:

Summary of post-treatment disease course measures from off-label medications clinical trials. by Filip Stanicic (17808254)

Subjects:

Summary of post-treatment CAPS score changes from clinical trials with psychotherapies. by Filip Stanicic (17808254)

Subjects:

Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes. by Filip Stanicic (17808254)

Subjects:

Summary of post-treatment disease course measures from clinical trials with psychotherapies. by Filip Stanicic (17808254)

Subjects:

Summary of clinical efficacy of relevant PTSD treatments. by Filip Stanicic (17808254)

Subjects:

Post-treatment CAPS score changes from clinical trials with off-label PTSD medications. by Filip Stanicic (17808254)

Subjects:

Catalytic fold of WT PARG1 C1-GAP domain for RhoA interaction. by Zen Kouchi (14898435)

Dynamic Covalent Chemistry Enabled Closed-Loop Recycling of Thermally Modified Polymer Membrane by Ching Yoong Loh (17863097)

“…Thermal and mechanical characterizations confirmed the great stability of the membranes, with the Diels–Alder reaction enabling depolymerization and reformation of the network without causing significant degradation. Additionally, the RFMs were recycled the third time, maintaining the fluxes (752 to 823 LMH) from the previous generation with a slight decrease in separation efficiency in dichloromethane-water emulsion separation (98.3 to 97%). …”

Dynamic Covalent Chemistry Enabled Closed-Loop Recycling of Thermally Modified Polymer Membrane by Ching Yoong Loh (17863097)

“…Thermal and mechanical characterizations confirmed the great stability of the membranes, with the Diels–Alder reaction enabling depolymerization and reformation of the network without causing significant degradation. Additionally, the RFMs were recycled the third time, maintaining the fluxes (752 to 823 LMH) from the previous generation with a slight decrease in separation efficiency in dichloromethane-water emulsion separation (98.3 to 97%). …”